Ray Dalio Nevro Corp Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Nevro Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 32,926 shares of NVRO stock, worth $307,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,926

Previous 37,833 12.97%

Holding current value

$307,858

Previous $814,000 41.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.56 - $20.78 $66,538 - $101,967	-4,907 Reduced 12.97%	32,926 $475,000
Q4 2023 Feb 14, 2024	SELL	$14.18 - $22.31 $62,874 - $98,922	-4,434 Reduced 10.49%	37,833 $814,000
Q3 2023 Nov 13, 2023	BUY	$18.22 - $25.85 $72,807 - $103,296	3,996 Added 10.44%	42,267 $812,000
Q2 2023 Aug 11, 2023	SELL	$22.62 - $39.32 $95,682 - $166,323	-4,230 Reduced 9.95%	38,271 $972,000
Q1 2023 May 12, 2023	BUY	$30.17 - $41.11 $47,246 - $64,378	1,566 Added 3.83%	42,501 $1.54 Million

Q4 2022 Feb 13, 2023	SELL	$36.43 - $49.4 $509,291 - $690,612	-13,980 Reduced 25.46%	40,935 $1.62 Million
Q3 2022 Nov 10, 2022	BUY	$40.66 - $53.03 $4,269 - $5,568	105 Added 0.19%	54,915 $2.56 Million
Q2 2022 Aug 11, 2022	BUY	$40.85 - $77.67 $248,163 - $471,845	6,075 Added 12.47%	54,810 $2.4 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $697,997 - $1.07 Million	11,643 Added 31.39%	48,735 $3.53 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $385,731 - $577,097	4,758 Added 14.72%	37,092 $3.01 Million
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $248,753 - $405,752	-2,439 Reduced 7.01%	32,334 $3.76 Million
Q2 2021 Aug 13, 2021	BUY	$141.6 - $179.06 $4.92 Million - $6.23 Million	34,773 New	34,773 $5.77 Million

Others Institutions Holding NVRO

# of Institutions

173

Shares Held

37.4M

Call Options Held

80.4K

Put Options Held

898K

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $331M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account